Search

everythinglearnresearchcommunity

for

Search:↓

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Consider amyloidosis in patients with specific nail changes and check for systemic issues.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Hair loss might be linked to eye aging due to inflammation markers in blood.

Finasteride treatment changes hormone levels in male pattern baldness patients.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

Hair loss linked to kidney stones in people under 60.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Detecting early breast arterial calcifications can help assess cardiovascular disease risk.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Kidney stones and hair loss are significantly related in people under 60 years old.

High YKL-40 levels predict early hair loss and hidden metabolic issues.

Multiphoton microscopy can effectively detect early endometrial cancer by analyzing collagen changes.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Finasteride and dutasteride may cause macular abnormalities.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Early hair loss may indicate risk of insulin resistance.

Finasteride reduces VEGF expression and microvascular growth in diabetic rat retinas.

Gray-scale ultrasound effectively detects erectile tissue fibrosis in young men with erectile dysfunction after using finasteride.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Hair follicles and urine cell pellets are promising for transcriptome studies.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.